Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Other Operating Expenses: 2022-2024

Historic Other Operating Expenses for GeneDx Holdings (WGS) over the last 3 years, with Dec 2024 value amounting to -$3.4 million.

  • GeneDx Holdings' Other Operating Expenses rose 60.03% to -$785,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.4 million, marking a year-over-year increase of 52.83%. This contributed to the annual value of -$3.4 million for FY2024, which is 52.83% up from last year.
  • GeneDx Holdings' Other Operating Expenses amounted to -$3.4 million in FY2024, which was up 52.83% from -$7.2 million recorded in FY2023.
  • In the past 5 years, GeneDx Holdings' Other Operating Expenses registered a high of -$3.4 million during FY2024, and its lowest value of -$7.2 million during FY2023.
  • Over the past 3 years, GeneDx Holdings' median Other Operating Expenses value was -$6.3 million (recorded in 2022), while the average stood at -$5.6 million.
  • Per our database at Business Quant, GeneDx Holdings' Other Operating Expenses fell by 14.43% in 2023 and then spiked by 52.83% in 2024.
  • Yearly analysis of 3 years shows GeneDx Holdings' Other Operating Expenses stood at -$6.3 million in 2022, then fell by 14.43% to -$7.2 million in 2023, then spiked by 52.83% to -$3.4 million in 2024.